Published in Transplantation on November 01, 1970
Increased frequency of rheumatoid factor precursor B lymphocytes after immunization of normal adults with tetanus toxoid. Clin Exp Immunol (1983) 1.88
Antibody-associated lymphotoxin in acute infection. J Clin Invest (1973) 1.34
Serum lymphocytotoxins in inflammatory bowel disease. Studies of frequency and specificity for lymphocyte subpopulations. Clin Exp Immunol (1975) 1.07
Characterization of cold reactive lymphocytotoxic antibodies in malaria. Clin Exp Immunol (1983) 0.90
Antihelper T cell autoantibody in acquired agammaglobulinemia. J Clin Invest (1981) 0.86
Cold-reactive lymphocytotoxins in Crohn's disease and ulcerative colitis. I. Incidence and characterization. Clin Exp Immunol (1982) 0.85
Autolymphocytotoxins in syphilis. Br J Vener Dis (1980) 0.84
Lymphocytotoxins in rheumatoid arthritis: prevalence, lymphocyte specificity, and HLA-DR antigens. Ann Rheum Dis (1981) 0.82
The relationship of autoantibodies to depression of cell-mediated immunity in infectious mononucleosis. Clin Exp Immunol (1975) 0.81
Cold reactive antilymphocyte antibodies in neurological diseases. J Neurol Neurosurg Psychiatry (1979) 0.80
Lymphocytotoxic antibodies in spontaneous cytomegalovirus infection. Br Med J (1978) 0.77
Lymphocytotoxins in leprosy and in asymptomatic hepatitis B virus infection. Clin Exp Immunol (1980) 0.77
Autoantibody against fibroblasts in renal transplant recipients: analysis by 51Cr-release assays. Clin Exp Immunol (1981) 0.75
Occurrence of lymphocytotoxins in multi-case rheumatoid arthritis families: relation to HLA. Clin Exp Immunol (1991) 0.75
High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med (1973) 9.90
Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test. Transplantation (1968) 8.51
The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40
Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture. Am J Clin Pathol (1978) 6.88
Significance of the positive crossmatch test in kidney transplantation. N Engl J Med (1969) 5.50
Autologous stimulation of human lymphocyte subpopulation. J Exp Med (1975) 4.80
Cytotoxins in disease. Autocytotoxins in lupus. N Engl J Med (1970) 4.40
Serotyping for homotransplantation. X. Survival of 196 grafted kidneys subsequent to typing. Transplantation (1967) 4.16
Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05
Kidney preservation for transportation. Initial perfusion and 30 hours' ice storage. Lancet (1969) 3.67
Effect of blood transfusions on subsequent kidney transplants. Transplant Proc (1973) 3.42
Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med (1993) 3.36
Nomenclature for factors of the HLA system, 2010. Tissue Antigens (2010) 3.22
Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med (1995) 3.11
Chronic survival after human renal homotransplantation. Lymphocyte-antigen matching, pathology and influence of thymectomy. Ann Surg (1965) 3.00
Passive hemagglutination procedures for protein and polysaccharide antigens using erythrocytes stabilized by aldehydes. J Immunol (1968) 2.72
Improvement of kidney-graft survival with increased numbers of blood transfusions. N Engl J Med (1978) 2.52
Transplantation of kidneys from donors whose hearts have stopped beating. N Engl J Med (1998) 2.48
Association of primary sclerosing cholangitis with HLA-DRw52a. N Engl J Med (1990) 2.40
Thoracic duct drainage before and after cadaveric kidney transplantation. Surg Gynecol Obstet (1979) 2.33
Heterologous antilymphocyte glubulin, histoincompatiblity matching, and human renal homotransplantation. Surg Gynecol Obstet (1968) 2.23
The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival. Transplantation (1995) 2.13
Equitable allocation of HLA-compatible kidneys for local pools and minorities. N Engl J Med (1994) 2.12
Reactivity of lymphocytes from normal persons on cultured tumor cells. Cancer Res (1973) 2.11
Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. The UNOS Scientific Renal Transplant Registry. N Engl J Med (1992) 2.09
Human renal transplants. I. Glomerular changes. Lab Invest (1967) 2.06
Characterization of sialosylated Lewisx as a new tumor-associated antigen. Cancer Res (1984) 2.02
Nomenclature for factors of the HLA system, 2002. Tissue Antigens (2002) 1.89
Analysis of HL-A incompatibility in human renal transplants. Tissue Antigens (1971) 1.89
A semimicro mixed leukocyte culture test. Transplantation (1971) 1.85
Juvenile myoclonic epilepsy (JME) may be linked to the BF and HLA loci on human chromosome 6. Am J Med Genet (1988) 1.82
Serotyping for homotransplantation. V. Evaluation of a matching scheme. Transplantation (1966) 1.78
Strain differentiation of Neisseria gonorrhoeae by reverse passive hemagglutination. Infect Immun (1979) 1.70
Enhancement of human kidney allografts by cold B-lymphocyte cytotoxins. Lancet (1978) 1.70
Spinocerebellar ataxia and HLA linkage: risk prediction by HLA typing. N Engl J Med (1977) 1.67
Multiple sclerosis: association with HL-A3. Tissue Antigens (1972) 1.65
Successful renal allografts across a positive cross-match for donor B-lymphocyte alloantigens. Lancet (1976) 1.63
Disturbance of HL-A antigen frequency in Psoriasis. N Engl J Med (1972) 1.63
Cross reactions between human transplantation antigens and bacterial lipopolysaccharides. Transplantation (1973) 1.60
Thoracic duct fistula and renal transplantation. Ann Surg (1979) 1.60
Influence of race on kidney transplant survival. Transplant Proc (1977) 1.58
Increased prevalence of W27 in juvenile rheumatoid arthritis. N Engl J Med (1974) 1.58
Treatment of lymphopenic hypogammaglobulinemia and bone-marrow aplasia by transplantation of allogeneic marrow. Crucial role of histocompatiility matching. N Engl J Med (1969) 1.58
Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity. Transfusion (2000) 1.58
Nomenclature for factors of the HLA system, 2004. Tissue Antigens (2005) 1.57
HLA matching and cadaver kidney transplant survival in North America: influence of center variation and presensitization. Transplantation (1977) 1.56
Empirical validation of the Essen-Möller probability of paternity. Am J Hum Genet (1986) 1.56
Follow-up study of juvenile chronic polyarthritis with particular reference to histocompatibility antigen W. 27. Ann Rheum Dis (1974) 1.55
Anti-HLA antibodies after solid organ transplantation. Transplantation (2000) 1.54
Impact of IgG3 subclass and C1q-fixing donor-specific HLA alloantibodies on rejection and survival in liver transplantation. Am J Transplant (2015) 1.50
HL-A antigens and antibody response after influenza A vaccination. Decreased response associated with HL-A type W16. N Engl J Med (1976) 1.49
HLA and the inheritance of multiple sclerosis: linkage analysis of 72 pedigrees. Am J Hum Genet (1980) 1.46
HLA genotypic study of insulin-dependent diabetes the excess of DR3/DR4 heterozygotes allows rejection of the recessive hypothesis. Diabetes (1983) 1.45
Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies. Am J Transplant (2013) 1.44
Suppression of lymphocyte transformation by aspirin. Lancet (1973) 1.43
Extremely high association between appearance of HLA antibodies and failure of kidney grafts in a five-year longitudinal study. Am J Transplant (2007) 1.43
Paired kidney exchange is not a solution to ABO incompatibility. Transplantation (1998) 1.43
Twins with two different fathers identified by HLA. N Engl J Med (1978) 1.43
LIGHT AND ELECTRON MICROSCOPIC STUDY OF BIOPSIES FROM THIRTY-THREE HUMAN RENAL ALLOGRAFTS AND AN ISOGRAFT 134-212 YEARS AFTER TRANSPLANTATION. Ann N Y Acad Sci (1996) 1.42
HL-A W27--a clue to the diagnosis and pathogenesis of Reiter's syndrome. N Engl J Med (1974) 1.41
Poor kidney-transplant survival in recipients with frozen-blood transfusions or no transfusions. Lancet (1974) 1.40
HLA matching assessed from early graft function. Transplant Proc (1987) 1.40
Nomenclature for factors of the HLA system, 1998. Tissue Antigens (1999) 1.40
Genetics of four new HL-A specificities in the Caucasian and Negro populations. Transplant Proc (1971) 1.38
Serotyping for homotransplantation. XIX. Experience with an interhospital scheme of cadaver-kidney sharing and tissue typing. JAMA (1969) 1.38
Analyses of the UNOS Scientific Renal Transplant Registry at three years--early events affecting transplant success. Transplantation (1992) 1.37
HLA-B14 antigen and postencephalitic Parkinson's disease. Their association in an American-Jewish ethnic group. Arch Neurol (1980) 1.37
Group-specific human granulocyte antigens on a chronic myelogenous leukemia cell line with a Philadelphia chromosome marker. Blood (1977) 1.35
Flow cytometric detection of HLA antibodies using a spectrum of microbeads. Hum Immunol (1999) 1.34
Cross-reactions between streptococcal M proteins and human transplantation antigens. Science (1970) 1.33
Presensitization and kidney transplant failures. Postgrad Med J (1971) 1.33
Serotyping for homotransplantation. IX. Evaluation of leukocyte antigen matching with the clinical course and rejection types. Transplantation (1967) 1.32
A new microcellular cytotoxicity test based on calcein AM release. Hum Immunol (1993) 1.32
Sjögren's syndrome association with HLA-Dw3. N Engl J Med (1977) 1.32
Serotyping for homotransplantation. XVI. Analysis of kidney transplants from unrelated donors. N Engl J Med (1968) 1.31
Close genetic linkage between diabetes mellitus and kidd blood group. Lancet (1981) 1.30
High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection Postliver transplant. Am J Transplant (2011) 1.29
Maternal-fetal incompatibility. I. Incidence of HL-A antibodies and possible association with congenital anomalies. Transplantation (1970) 1.28
Defective T cell function in atopic dermatitis. J Allergy Clin Immunol (1976) 1.26
HLA-linked and unlinked determinants of multiple sclerosis. Immunogenetics (1982) 1.25
HLA-DRW4 in 91% of Jewish pemphigus vulgaris patients. Lancet (1979) 1.23
National allocation of cadaveric kidneys by HLA matching. Projected effect on outcome and costs. N Engl J Med (1991) 1.23
De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival. Am J Transplant (2011) 1.22
The use of a specific antibody adsorbent for estimation of total antibody against bovine serum albumin. Immunochemistry (1965) 1.22
Nomenclature for factors of the HLA system, 2000. Tissue Antigens (2001) 1.21
Public determinants of HLA indicated by pregnancy antibodies. Transplantation (1986) 1.20
Twelve years' experience with national sharing of HLA-matched cadaveric kidneys for transplantation. N Engl J Med (2000) 1.18
Nomenclature for factors of the HLA system, 1996. Tissue Antigens (1997) 1.18
Induction of high kidney graft survival rate by multiple transfusion. Lancet (1981) 1.18
HL-A haplotypes of 32 diseases. Transplant Rev (1975) 1.18
HLA-A2 and type 2 (insulin independent) diabetes mellitus in Pima Indians: an association of allele frequency with age. Diabetologia (1981) 1.16
Identification of unresponsive kidney-transplant recipients. Lancet (1972) 1.16
HL-A W27 in psoriatic arthropathy. Arthritis Rheum (1975) 1.14
Multiple sclerosis and high incidence of a B lymphocyte antigen. Science (1976) 1.14
Human B-lymphocyte antigens expressed by lymphocytic and myelocytic leukemia cells. II. Detection by human anti-B-cell alloantisera. J Natl Cancer Inst (1977) 1.14
HL-A-W27--a useful discriminator in the arthropathies of inflammatory bowel disease. N Engl J Med (1974) 1.13